Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Moon-bound Artemis II astronauts enjoy a relaxed day in space - 2Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer
- 3Volunteers aiding humpback whale stranded in Baltic get death threats
- 4Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- 5Investigating Free Cell Phones: What You Really want to Be aware
- Orbán orders stop to gas deliveries to Ukraine via Hungary from July
- Sarkozy says he owes France 'the truth' as he challenges conviction over alleged Libya funding
- How to avoid or deal with an outrageous medical bill
- NASA astronauts to return from space early due to an 'unexpected medical issue.' What happened — and when are they coming home?
- NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
- Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz
- Most loved Seared Chicken: Which Chain Rules?
- 5 Great Crossover Vehicles For Eco-friendliness In 2024
- Figure out How to Streamline Your Profits in Gold Speculation
